Bio

Over 25 years of research experience in cell-based therapeutics, rare disease, immuno-oncology, immunology & inflammation, cell & molecular biology, cell biology, and structural biology, leading to several important experimental and marketed therapies. Strong executive experience, including multi-facility management (>160 FTEs), pipeline review, and product & technology licensing. - Product and technology prospecting, evaluation & internalization - Preclinical drug discovery (peptides, nucleotides, biologics, conjugates, cell therapies) - Cell biology (signal transduction, imaging, cytometry, iPSC, T, and B cell therapeutics) - mAb generation and characterization